Stellate Gnaglion Block in Refractory Bell's Palsy
Facial Palsy, Neuropathy
About this trial
This is an interventional treatment trial for Facial Palsy focused on measuring neuropathy
Eligibility Criteria
Inclusion Criteria:
- Diagnosed by clinical and neurological assessment as one-sided idiopathic facial palsy
- Age 18 to 60
- ASA Ⅰ~Ⅲ
Exclusion Criteria:
- diabetic
- coagulation dysfunction
- mental or cognitive dysfunclion
- allergy to injected medication
Sites / Locations
- Emad Zarief Kamel Said
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Stellate ganglion block
Conventional
Patients underwent a stellate-ganglion block at the anterolateral aspect of the C6 vertebra. After local analgesia (lidocaine 2%), a 22-gauge Quincke needle was placed in the anterolateral aspect of the C6 vertebral body. When the needle contacted the bone, it was drawn back 1 mm. 5 mL of 0·5% ropivacaine was subsequently injected next to the stellate ganglion to produce a sympathetic block.The effect of the stellate-ganglion block on the sympathetic nervous system was confirmed by the presence of Horner's syndrome (ie, facial anhydrosis, enophthalmos, ptosis, swelling of the lower eyelid, miosis, and blood-shot conjunctiva), and an increase in the temperature of the right hand of at least 2°F from baseline.
Mecobalamin Tablets oral Mecobalamin Tablets tid-8